CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Maria Gabriella Raimondo, Nicolai A. Kittan et al.|Annals of the Rheumatic Diseases|2024Cited by 150
Bispecific T cell engager therapy for refractory rheumatoid arthritisLaura Bucci, Ricardo Grieshaber‐Bouyer, Melanie Hagen et al.|Nature Medicine|2024Cited by 147
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune DiseaseMelanie Hagen, Ricardo Grieshaber‐Bouyer, Laura Bucci et al.|New England Journal of Medicine|2024Cited by 111
Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical studentsJohannes Knitza, Axel J. Hueber, Koray Taşçılar et al.|Arthritis Research & Therapy|2021Cited by 42
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Maria Gabriella Raimondo, Markus Eckstein et al.|Annals of the Rheumatic Diseases|2025Cited by 35